Erythroleukoplakia clinical trials at UCSD

1 in progress, 0 open to eligible people

Showing trials for

  • Pembrolizumab in Treating Participants With Leukoplakia

    Sorry, not currently recruiting here

    This phase II pilot trial studies how well pembrolizumab works in treating leukoplakia. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.

    La Jolla, California and other locations

Our lead scientists for Erythroleukoplakia research studies include .

Last updated: